Featured
< Back to NewsApril 22, 2024
Recent Changes to the Federal Rules of Evidence Governing the Admissibility of Expert Testimony Effective December 1, 2023, the Federal Rules of Evidence relating to the admissibility of expert testimony were amended. The Federal Advisory Committee on Evidence Rules (the “Committee”) indicated that Rule 702 (Testimony by Expert Witness) was amended in order to clarify... Read More
January 19, 2024
Federal Circuit Affirms Use of Skinny Label for Vortioxetine In December 2023, the United States Court of Appeals for the Federal Circuit affirmed a district court’s opinion regarding noninfringement of two patents related to specific uses of the antidepressant drug Trintellix® (vortioxetine). This opinion reaffirmed the use of the “section viii” statement, allowing companies... Read More